New hope in the fight against RSV
Researchers discover promising drug candidate
13-Feb-2024 -
The respiratory syncytial virus (RSV) causes severe lower respiratory tract infections, particularly in young children. To date, there is neither an antiviral therapy against the virus nor a vaccination for children. This is why researchers led by Thomas Pietschmann at TWINCORE, a joint ...
drug discovery
drug screening
respiratory syncytial virus (RSV)